LoginSignup
immagine del profilo
Tobi
@Toname
3Settimana·

What's going on at $CVS (-2,65%) going on? Does anyone know anything? 😅

3
16 Commenti
immagine del profilo
Ronald@AlterMann
3Settimana
My daughter is supposed to collect the news about her shares and always explain something to me. Do you do that too?
•
10
•
Mostra la risposta
immagine del profilo
port01_andy@port01_andy
3Settimana
so I went in hard at 51.04 euros ..... should be a little higher tonight :-)
•
4
•
Visualizza tutti 2 ulteriori risposte
immagine del profilo
Frokker@mehrReingewinn
3Settimana
In the course of the management change, the company also published preliminary financial figures for the third quarter. CVS Health expects GAAP earnings per share (EPS) between $0.03 and $0.08 and adjusted EPS of $1.05 to $1.10. This guidance includes a charge of $1.1 billion for premium deficiency reserves, primarily from the Medicare and Individual Exchange businesses, which reduced adjusted EPS by $0.63. Most of these reserves are expected to be released in the fourth quarter, which should have a positive impact on future results.
In addition, CVS Health recorded restructuring charges of approximately $1.2 billion due to planned store closures for 2025 and cost reduction measures. The Medical Benefit Ratio for the quarter is expected to be approximately 95.2%, including a 220 basis point impact from premium deficiency reserves. Investors are cautioned not to rely on the guidance released on August 7, 2024 as increased medical cost burdens continue to exist. Further updates are expected in the upcoming quarterly results conference call on 06.11.2024.
•
3
•
Mostra la risposta
immagine del profilo
Daniel@Smokehead
3Settimana
CEO change and outlook lowered once again
•
2
•
Mostra la risposta
immagine del profilo
PiHu@PiHu
3Settimana
WOONSOCKET, R.I. - CVS Health (NYSE:CVS) announced a significant leadership change with David Joyner taking over as President and Chief Executive Officer, effective last Thursday. Joyner, with a 37-year background in healthcare and pharmacy benefit management, succeeds Karen Lynch. Concurrently, Roger Farah transitions from Chairman to Executive Chairman of the Board.
•
1
•
Mostra la risposta
immagine del profilo
Bullnbear@Bullnbear
3Settimana
Dividends ex day?
••
Visualizza tutti 4 ulteriori risposte
Partecipa alla conversazione
IscrivitiAccesso